Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial—VIP report no. 1


Published in:
Ophthalmology, 108, 5, 841-852
Year:
2001
Note:
Verteporfin in Photodynamic Therapy (VIP) Study Group
Laboratories:




 Record created 2011-02-01, last modified 2018-01-28


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)